These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

988 related items for PubMed ID: 9078349

  • 1. Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment.
    Shizuru JA, Jerabek L, Edwards CT, Weissman IL.
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):3-14. PubMed ID: 9078349
    [Abstract] [Full Text] [Related]

  • 2. High doses of purified stem cells cause early hematopoietic recovery in syngeneic and allogeneic hosts.
    Uchida N, Tsukamoto A, He D, Friera AM, Scollay R, Weissman IL.
    J Clin Invest; 1998 Mar 01; 101(5):961-6. PubMed ID: 9486965
    [Abstract] [Full Text] [Related]

  • 3. Facilitating cells enable engraftment of purified fetal liver stem cells in allogeneic recipients.
    Gaines BA, Colson YL, Kaufman CL, Ildstad S.
    Exp Hematol; 1996 Jul 01; 24(8):902-13. PubMed ID: 8690049
    [Abstract] [Full Text] [Related]

  • 4. Osteoblasts promote engraftment of allogeneic hematopoietic stem cells.
    El-Badri NS, Wang BY, Cherry, Good RA.
    Exp Hematol; 1998 Feb 01; 26(2):110-6. PubMed ID: 9472800
    [Abstract] [Full Text] [Related]

  • 5. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL, Wren SM, Schuchert MJ, Patrene KD, Johnson PC, Boggs SS, Ildstad ST.
    J Immunol; 1995 Nov 01; 155(9):4179-88. PubMed ID: 7594573
    [Abstract] [Full Text] [Related]

  • 6. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
    Drobyski WR, Majewski D, Ozker K, Hanson G.
    J Immunol; 1998 Sep 01; 161(5):2610-9. PubMed ID: 9725263
    [Abstract] [Full Text] [Related]

  • 7. Hematopoietic cell transplantation for the induction of allo- and xenotolerance.
    Sykes M.
    Clin Transplant; 1996 Aug 01; 10(4):357-63. PubMed ID: 8884109
    [Abstract] [Full Text] [Related]

  • 8. Chimerism and tolerance: from freemartin cattle and neonatal mice to humans.
    Jankowski RA, Ildstad ST.
    Hum Immunol; 1997 Feb 01; 52(2):155-61. PubMed ID: 9077564
    [Abstract] [Full Text] [Related]

  • 9. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z, Shatry A, Deyev V, Podack E, Mammolenti M, Blazar BR, Yagita H, Levy RB.
    Biol Blood Marrow Transplant; 2005 Aug 01; 11(8):576-86. PubMed ID: 16041307
    [Abstract] [Full Text] [Related]

  • 10. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.
    Jones SC, Murphy GF, Korngold R.
    Biol Blood Marrow Transplant; 2003 Apr 01; 9(4):243-56. PubMed ID: 12720217
    [Abstract] [Full Text] [Related]

  • 11. Cytokines and cytotoxic pathways in engraftment resistance to purified allogeneic hematopoietic stem cells.
    Scheffold C, Scheffold YC, Cao TM, Gworek J, Shizuru JA.
    Biol Blood Marrow Transplant; 2005 Jan 01; 11(1):1-12. PubMed ID: 15625539
    [Abstract] [Full Text] [Related]

  • 12. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S.
    Blood Cells Mol Dis; 2008 Jan 01; 40(1):48-54. PubMed ID: 17827036
    [Abstract] [Full Text] [Related]

  • 13. [Role of alloreactive natural killer cell in mouse MHC haploidentical bone marrow transplantation].
    He Y, Wang HH, Wang M, Zhou Z, Zhai WJ, Huang Y, Jiang EL, Wang ZD, Zhou SY, Liu QG, Feng SZ, Han MZ.
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb 01; 27(2):82-6. PubMed ID: 16732957
    [Abstract] [Full Text] [Related]

  • 14. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
    Pelot MR, Pearson DA, Swenson K, Zhao G, Sachs J, Yang YG, Sykes M.
    Biol Blood Marrow Transplant; 1999 Feb 01; 5(3):133-43. PubMed ID: 10392959
    [Abstract] [Full Text] [Related]

  • 15. Effects of T cell depletion in radiation bone marrow chimeras. I. Evidence for a donor cell population which increases allogeneic chimerism but which lacks the potential to produce GVHD.
    Sykes M, Sheard M, Sachs DH.
    J Immunol; 1988 Oct 01; 141(7):2282-8. PubMed ID: 3049804
    [Abstract] [Full Text] [Related]

  • 16. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May 01; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 17. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY, Pelot M, Zhao G, Swenson K, Pearson D, Sykes M.
    Biol Blood Marrow Transplant; 2001 May 01; 7(12):646-55. PubMed ID: 11787527
    [Abstract] [Full Text] [Related]

  • 18. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR, Majewski D, Hanson G.
    Biol Blood Marrow Transplant; 1999 May 01; 5(4):222-30. PubMed ID: 10465102
    [Abstract] [Full Text] [Related]

  • 19. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM, Gorechlad J, Larsen CP, Waller EK.
    Biol Blood Marrow Transplant; 2006 Dec 01; 12(12):1239-49. PubMed ID: 17162205
    [Abstract] [Full Text] [Related]

  • 20. In vivo administration of anti-CD3 monoclonal antibodies or immunotoxins in murine recipients of allogeneic T cell-depleted marrow for the promotion of engraftment.
    Blazar BR, Hirsch R, Gress RE, Carroll SF, Vallera DA.
    J Immunol; 1991 Sep 01; 147(5):1492-503. PubMed ID: 1831826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.